ABSTRACT
Objective To observe the clinical effect ofShuganJieyu capsule combined with domperidone on functional dyspepsia (FD).Methods84 FD patients were recruited in this study. The patients were divided into the control group (n=42) and the observation group (n=42). Control group was treated with domperidone, and observation group was treated with combination ofShuganJieyu capsule and domperidone. Both groups were treated for 4 weeks. The gastric volume, gastric gas scores, and gastric emptying rates were detected by the ultrasound and X-ray. The clinical effect and adverse reactions was compared.ResultsThe clinic effective rate of observation group was 90.5% (38/42), and the control group was 76.2% (32/42). After treatment, the gastric volume of 60 min was significantly lower in observation group than that in control group (15.52 ± 3.21 mlvs. 23.54 ± 5.11 ml;t=2.412,P<0.05); the decreasing of gastric gas scores (0.42 ± 0.13vs. 0.64 ± 0.16;t=2.384,P<0.05) and increasing of gastric emptying rate (74.15% ± 11.62%vs. 54.82% ± 10.31%;t=2.324,P<0.05) were significantly higher in observation group than those in control group.ConclusionShugan-Jieyu capsule can improve gastric emptying and gastrointestinal motility, and showed better effect than domperidone alone.
ABSTRACT
Objective To investigate the effect of electroacupuncture on hypothalamic and hippocampal expressions of ghrelin and ghrelin receptor (GHS-R) mRNA in functional dyspepsia (FD) rats. Methods Eighty SD rats were randomly allocated to normal control, model control, medication and electroacupuncture groups, 20 rats each. A rat model of FD was made by tail clamp modeling method. The medication group received an oral gavage of cisapride solution and the electroacupuncture group, electroacupuncture treatment. The expressions of ghrelin protein and GHS-R mRNA in the hypothalamus and hippocampus were examined by Western blot and real-time PCR, respectively, in all the four groups. Results Compared with the model control group of rats, the expression of ghrelin protein in the hypothalamus and the expression of GHS-R mRNA in the hypothalamus and hippocampus increased in the medication group (P<0.05) and the expressions of ghrelin protein and GHS-R mRNA in the hypothalamus and hippocampus were up-regulated in the electroacupuncture group (P<0.05). Compared with the medication group of rats, the expressions of ghrelin protein and GHS-R mRNA in the hippocampus were up-regulated in the electroacupuncture group (P<0.05). Conclusions Electroacupuncture and medication can improve gastrointestinal functions and correct an imbalance in the brain-gut axis through the hippocampus-hypothalamic pathway by regulating hypothalamic and hippocampal ghrelin protein and GHS-R mRNA contents and activating hypothalamic neurons and hippocampal excitatory synapses.
ABSTRACT
Functional dyspepsia(FD)is a commonly seen gastrointestinal disease. Dyspepsia symptom scale and quality of life questionnaire are two objective approaches for evaluating the efficacy of intervention measures on FD. This article reviewed the advances in study on evaluation of FD by dyspepsia symptom scale and quality of life questionnaire.
ABSTRACT
Objective To evaluate the efficacy and safety of trimebutine combined with mosapride on functional dyspepsia. Methods Patients with functional dyspepsia were randomly divided into three clinical groups. Group A (n=116) received 0.2 g trimebutine after meal,group the drug combination B (n=116) received 5 mg mosapride before meal,and the drug combination group (n=115) received 0. 2 g trimebutine after meal plus 5 mg mosapride before meal. All medications were taken orally three times daily for 4 weeks. Improvement in clinical symptoms and adverse reactions in each group were evaluated at the end of study. Results A total of 339 patients among 347 enrollees completed the treatment and follow-up. The clinical efficacy on postprandial fullness, early satiation, epigastric pain, epigastric burning, upper abdominal bloating and nausea were 88. 4%,76. 9%,72. 9%,61. 8%,86. 7% and 81. 7%,respectively in the drug combination group after 4-week treatment,which were superior to those in group A or B (P<0. 05) except for epigastric burning. The total effective rate of the drug combination group was 78. 8%,significantly higher than the other two groups (P<0. 05). The total incidence of side effects in the drug combination group was 1. 8%,similar to that of group A and B (1. 8% and 0. 9%,respectively, P =0. 776). Conclusion Trimebutine combined with mosapride is safe and effective for improving symptoms in functional dyspepsia.
ABSTRACT
Objective To Investigate the psychological health status of the patients with functional dyspepsia (FD).Methods A total of 80 patients with FD were chosen at random from Ji-Shui-Tan Hospital GI department and 80 normal control were selected from January,2006 to January,2007.MMPI was used as assessment tool.Results Patients with FD have higher scores in hypochondriasis,depression,hysterism,psychasthenia and paranoia than normal control group (P